期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 9, 期 9, 页码 510-519出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2012.111
关键词
-
类别
资金
- NIH [P01CA094237, P50CA126752, U54HL08100]
- SCOR award from the Leukemia and Lymphoma Society
Post-transplant lymphoproliferative diseases (PTLD) associated with Epstein-Barr virus (EBV) infection often develop after organ and haematopoietic stem-cell transplantation. These lymphoproliferative diseases are tumours that usually express all latent EBV viral proteins, and are therefore amenable to T-cell-based immune therapies, such as donor lymphocyte infusions and the adoptive transfer of EBV-specific cytotoxic T lymphocytes. In this Review, we describe current approaches of T-cell-based therapies to treat PTLD, and describe strategies that improve the feasibility of such treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据